Clues Therapeutics

Clues Therapeutics is a private oncology-focused biotechnology company founded in 2018 by drug discovery veteran Dr. Bingchu Deng. The company is developing first-in-class and best-in-class small molecule therapeutics and describes its approach as integrating multiple target-screening and drug discovery technologies to improve R&D efficiency. Publicly visible information indicates an early-stage pipeline centered on oncology, with at least one disclosed patent family covering pyrazolo[1,5-a]pyridine derivatives as RET inhibitors. The company appears to operate through entities in the Cayman Islands, Hong Kong, and Shanghai, and has been associated with Viva BioInnovator and investors including Viva Ventures Biotech Fund and JMCR Partners.